The 33 companies powering the Chengdu · Dayi · Anren Biotech Belt ecosystem — a world-class alliance driving the future of peptide therapeutics, biologics, and gene-mRNA innovation.
Together, we are advancing global healthcare, reducing costs, and delivering life-changing therapies to 50+ countries worldwide.
From national heavyweights to future tech leaders — the full biotech supply chain is here. This ecosystem represents over ¥200B in combined market capitalization and 60% of global peptide API production.